Tyler Westcott

Vice President, CMC at AN2 Therapeutics

Tyler Westcott has extensive work experience in the pharmaceutical industry. Tyler began their career at Alza Corporation, where they worked as an Engineer for several drug product development programs. Tyler served as the Technical Lead for developing a novel transdermal bisoprolol drug product. At Dharma Therapeutics, Tyler worked as a Senior Engineer, developing iontophoretic drug products and collaborating with CMOs to optimize manufacturing processes.

Tyler then joined Anacor Pharmaceuticals as an Associate Director of Process Development. During their time there, they played a key role in launching two commercial topical drug products and authored NDA drug product sections. At PellePharm, they served as the Director and later Sr. Director of Drug Product Development.

Currently, Tyler is working at AN2 Therapeutics as the Sr. Director of Drug Product Development and recently transitioned to the role of Vice President, CMC.

Tyler Westcott attended Queen's University from 1996 to 2000, where they obtained a Bachelor of Science degree in Engineering Chemistry.

Links

Previous companies

PellePharm logo

Timeline

  • Vice President, CMC

    February, 2022 - present

  • Sr. Director, Drug Product Development

    May, 2021